mHealth Israel

Charlie Chappell, Hersheys; Ryuta Otsuka (Nisshin Oillio) and Luba Safran (Mondelez International) lead investments and partnership strategy at three global food giants. They track trends and technologies reshaping the way people eat, live, and engage with food. On Thursday, September 18th, join an in-depth discussion with these thought-leaders, moderatd by Rachel Kay (FINN Partners):

Title: FoodTech- Future Forward© (Hersheys, Mondelez, Nisshin)
Date: Thursday, September 18th
Time: 9am ET / 4pm IL
Access: Zoom URL (coming soon)
Speakers:

• Charlie Chappell, Vice President, Innovation and R&D, Hersheys
• Ryuta Otsuka, Strategic Partnerships, Nisshin Oillio
• Luba Safran, Investment Lead, SnackFutures Ventures, Mondelez International

The conversation will break down how corporates assess emerging solutions and the logic behind those billion dollar bets. If you are building for scale, this belongs on your radar.

This is a paid event. FREE admission is available for the mHealth Israel community. Contact levi.shapiro@gmail.com for the confidential code, which can be input on the registration page of the Galien Forum website HERE

Note: Responding to this meetup announcement will NOT enable actual registration. Please request the confidential code and then input that during the online registration process at the Galien Forum website HERE

Audience: Senior R&D and corporate development executives focused on Biotechnology, Pharmaceutical and Rare/Orphan Diseases
Event: Galien Forum 2025 (including the inaugural Galien Patient Summit)
Date: October 30th
Time: 8am-4:15pm ET
Address: Alexandria Life Science Center, West Tower, 430 East 29th Street, New York, NY 10016
Cost: PAID event but free admission is available for the mHealth Israel community. Contact levi.shapiro@gmail.com for the confidential code.

Awards Committee 2025
Michael ROSENBLATT
M.D., Galien Forum Co-Chair, Former Dean of Tufts University School of Medicine, and former Chief Medical Officer of Merck & Co. Inc.
Linda BUCK
Ph.D., Nobel Laureate, Fred Hutchinson Cancer Research Center member; Professor of Physiology and Biophysics, University of Washington
Sue DESMOND-HELLMANN
M.D., M.P.H., Former Chief Executive Officer, Bill & Melinda Gates Foundation
Laurie GLIMCHER
M.D., President and CEO, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School
Mary-Claire KING
Ph.D., American Cancer Society Professor of Genome Sciences and Medical Genetics, University of Washington
Robert S. LANGER
M.D., David H. Koch Institute Professor, Massachusetts Institute of Technology
Sir Cato T. LAURENCIN
M.D., Ph.D., K.C.S.L., Chief Executive Officer, The Cato T. Laurencin Institute at UConn; The University Professor and Van Dusen Distinguished Endowed Professor, University of Connecticut
Steven J. LESTER
M.D., Medical Director, Discovery Oasis; Founder and Chief Medical Officer, Mayo Clinic and ASU Alliance for Health Care Accelerator
Stanley B. PRUSINER
M.D., Nobel Laureate, Professor of Neurology, Director, Institute for Neurodegenerative Diseases, University of California, San Francisco
Phillip A. SHARP
Ph.D., Nobel Laureate, Professor of Biology and member of the Koch Institute, Chair of the advisory board of the MIT Jameel Clinic
Marc TESSIER-LAVIGNE
Ph.D., President Emeritus and Professor, Stanford University

About The Galien Foundation
The Galien Foundation fosters, recognizes, and rewards excellence in scientific innovation to improve the state of human health. The vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives. The late Professor Elie Wiesel, 1986 Peace Nobel Laureate, is The Honorary Founding President of The Galien Foundation

Change has been fast and furious in the last couple of years. On December 8th, let's try something different...a few hours dedicated toward contemplating The Road Ahead, across key sectors driving fundamental change, including the following:
- Medical
- Sustainability / Climate
- Quantum
- AI
- Investment
- Regulation
Hosted by the incomparable Gil Bashe.

"2026- The Road Ahead" provides visionary analysis from sector experts driving change across domains:

• Medical (Boston Scientific execs, including Jonathan Goldstein)
• Quantum (Maya Netser, Qbeat Ventures)
• Artificial General Intelligence (NVIDIA invited)
• Sustainability
• SpaceTech
• Investment (VC panel)
• B2C (Danny Cohen, Sticker VC)
• Regulation (Noga Spira, NBA)

Title: 2026- The Road Ahead
Date: Monday, December 8th
Time: 9am-12:30pm (includes food and beverage)
Address: NBA law firm- Tuval St 5, Tel Aviv-Yafo, 6789717
Speakers (more to come): Gil Bashe, Jonathan Goldstein, Maya Netser, Noga Spira

See you on Monday, December 8th, 9am-12:30pm for "2026- The Road Ahead".

Reimbursement is a laborious, expensive process, requiring the same amount of resources (human, financial and time) as FDA. Yet, too often, this crucial step is overlooked. On Sunday, June 15th, 9-11am, David Farber, Head of Reimbursement at King & Spalding LLC, will lead a 90 minute Reimbursement Bootcamp, followed by your Q&A. As a reference, please see David's previous Bootcamp lecture HERE

Title: Reimbursement Bootcamp for MedTech and Digital Health
Date: Rescheduled to December.
Time: 9-11am
Lecture: Link HERE
Agenda: Introductory remarks from Goel Jasper, followed by lecture from David Farber.
Venue: Herzog law firm, Yitzhak Sadeh St 6, Tel Aviv-Yafo, 6777506, Israel

Essential insights for medtech / digital health / biotech companies that actually want to MAKE MONEY in the US.